Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"

Authors :: Cheng L
Nelson BC
Mehta M
Shi Q
Gomez-Simmonds A
Uhlemann AC
Source :: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Aug 24; Vol. 61 (9). Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).
Publication Year :: 2017

Subjects :: Anti-Bacterial Agents
Bacterial Proteins
Microbial Sensitivity Tests
Penicillanic Acid analogs & derivatives
Tazobactam
beta-Lactamase Inhibitors
beta-Lactamases
Enterobacteriaceae
Piperacillin

Full Text Access

Tools